Catalyst Watch: Amazon Prime Day, Delta earnings and stock-by-stock trade deal implications
Source: SeekingAlpha
2025-07-04 12:00:09 ET
More on SPDR S&P 500 ETF Trust
- June Jobs Report Is Nail In The Coffin, No July Rate Cut
- The Market Is Priced For Perfection In A Very Imperfect World
- June Jobs Report: The Strong U.S. Labor Market Will Not Be An Excuse To Cut In July
- Market Voices: June jobs report, Ford CEO warns on AI, UPS buyouts
- Is the stock market open on July 4?
Read the full article on Seeking Alpha
For further details see:
Catalyst Watch: Amazon Prime Day, Delta earnings and stock-by-stock trade deal implications
Citius Oncology Inc.
NASDAQ: CTOR
CTOR Trading
-8.86% G/L:
$0.82 Last:
275,721 Volume:
$0.93 Open:
CTOR Latest News
March 10, 2026 08:47:00 am
Citius Oncology Announces Positive Topline Results from Investigator?Initiated Phase 1 Study of LYMPHIR(TM) in Combination with Pembrolizumab in Relapsed or Refractory Gynecologic Cancers
March 04, 2026 09:15:00 am
Citius Oncology Announces Preliminary Topline Phase 1 Data from Study of LYMPHIR(TM) (E7777) Dosing Prior to Commercial CAR?T Therapy in High?Risk Diffuse Large B?Cell Lymphoma
February 17, 2026 08:24:00 am
The FDA Cleared 50 Oncology Approvals in 2025 and the Pipeline Keeps Accelerating
February 13, 2026 08:00:00 am
Citius Pharmaceuticals, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR(TM)
